These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9741861)

  • 1. Sample size determination for controlling the upper confidence limit of incidence rate of a binomial endpoint.
    Shen LZ
    J Biopharm Stat; 1998 Jul; 8(3):489-96. PubMed ID: 9741861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidence intervals for a ratio of two independent binomial proportions.
    Price RM; Bonett DG
    Stat Med; 2008 Nov; 27(26):5497-508. PubMed ID: 18781560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional power calculations for clinical trials with historical controls.
    Korn EL; Freidlin B
    Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
    Yue LQ; Roach P
    J Biopharm Stat; 1998 Nov; 8(4):577-84. PubMed ID: 9855035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of small health risks based on exact sample sizes.
    Abt K; Gülich A
    Stat Med; 1996 Jan; 15(2):183-95. PubMed ID: 8614754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
    Wang J
    J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exact tests using two correlated binomial variables in contemporary cancer clinical trials.
    Yu J; Kepner JL; Iyer R
    Biom J; 2009 Dec; 51(6):899-914. PubMed ID: 20014199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size tables for exact single-stage phase II designs.
    A'Hern RP
    Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conditional binomial test revisited for clinical trials.
    Lei X; Davis D; Kuan L; Lee J; Oh S
    J Biopharm Stat; 1998 Nov; 8(4):533-43. PubMed ID: 9855032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size in clinical trials with dichotomous endpoints: use of covariables.
    Choi SC
    J Biopharm Stat; 1998 Jul; 8(3):367-75. PubMed ID: 9741853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic statistics for clinicians: 2. Interpreting study results: confidence intervals.
    Guyatt G; Jaeschke R; Heddle N; Cook D; Shannon H; Walter S
    CMAJ; 1995 Jan; 152(2):169-73. PubMed ID: 7820798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confidence intervals based on some weighting functions for the difference of two binomial proportions.
    Maruo K; Kawai N
    Stat Med; 2014 Jun; 33(13):2288-96. PubMed ID: 24644149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I error in sample size re-estimations based on observed treatment difference.
    Shun Z; Yuan W; Brady WE; Hsu H
    Stat Med; 2001 Feb; 20(4):497-513. PubMed ID: 11223896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
    Friede T; Schmidli H
    Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.